EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis

Ram Hari Dahal, Shukho Kim, Yu Kyung Kim, Eun Soo Kim, Jungmin Kim

Frontiers in Microbiology · 11.05.2023 · 14

DOI: 10.3389/fmicb.2023.1174832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 11.05.2023. Verfasst von Ram Hari Dahal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The collection of whole microbial communities (bacteria, archaea, fungi, and viruses) together constitutes the gut microbiome. Diet, age, stress, host genetics, and diseases cause increases or decreases in the relative abundance and diversity of bacterial species (dysbiosis). We aimed to investigate the gut microbial composition at different taxonomic levels of healthy controls (HCs) with active Crohn’s disease (CD), ulcerative colitis (UC), and ischemic colitis (IC) using culture- and non-culture-based approaches and identify biomarkers to discriminate CD, UC, or IC. We determined the specific changes in the gut microbial profile using culture-independent (16S rRNA gene amplicon sequencing) as well as culture-based (culturomic) approaches. Biomarkers were validated using quantitative Real-Time PCR (qPCR). In both methods, bacterial diversity and species richness decreased in disease-associated conditions compared with that in HCs. Highly reduced abundance of Faecalibacterium prausnitzii and Prevotella sp. and an increased abundance of potentially pathogenic bacteria such as Enterococcus faecium , Enterococcus faecalis , and Escherichia coli in all CD, UC, or IC conditions were observed. We noted a high abundance of Latilactobacillus sakei in CD patients; Ligilactobacillus ruminis in UC patients; and Enterococcus faecium , Escherichia coli , and Enterococcus faecalis in IC patients. Highly reduced abundance of Faecalibacterium prausnitzii in all cases, and increased abundance of Latilactobacillus sakei and Enterococcus faecium in CD, Ligilactobacillus ruminis and Enterococcus faecium in UC, and Enterococcus faecium , Escherichia coli , and Enterococcus faecalis in IC could be biomarkers for CD, UC, and IC, respectively. These biomarkers may help in IBD (CD or UC) and IC diagnosis.

Schlagwörter

Stichwörter der Autor:innen

biomarkerculturomicsgut dysbiosisgut microbiomeinflammatory bowel diseaseischemic colitisprobioticsuncultured gut bacteria

Autor:innen und Institutionen

  • Department of Microbiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

Zitieren

APA

Dahal, R. H., Kim, S., Kim, Y. K., Kim, E. S., & Kim, J. (2023). Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1174832

Vancouver

Dahal RH, Kim S, Kim YK, Kim ES, Kim J. Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1174832

BibTeX
@article{Dahal2023,
  author = {Dahal, Ram Hari and Kim, Shukho and Kim, Yu Kyung and Kim, Eun Soo and Kim, Jungmin},
  title = {Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis},
  journal = {Frontiers in Microbiology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fmicb.2023.1174832}
}
Kostenlos starten →